BiotechTube
Home/Heartseed/Takehiko Kaneko
TK

Takehiko Kaneko

CMO, Director

Heartseed

Therapeutic Areas

Cardiovascular

Heartseed Pipeline

DrugIndicationPhase
HS-001Systolic Heart Failure (HFrEF) including Dilated Cardiomyopathy (DCM), Old Myocardial Infarction (OMI), Dilated-phase Hypertrophic Cardiomyopathy (D-HCM)Phase 1

Leadership Team at Heartseed

KF
Keiichi Fukuda
CEO, Representative Director
KY
Kikuo Yasui
COO, Director
View full Heartseed profile